Correlation Between Esperion Therapeutics and Pacira BioSciences,
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and Pacira BioSciences,, you can compare the effects of market volatilities on Esperion Therapeutics and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and Pacira BioSciences,.
Diversification Opportunities for Esperion Therapeutics and Pacira BioSciences,
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Esperion and Pacira is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and Pacira BioSciences, go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and Pacira BioSciences,
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 2.55 times more return on investment than Pacira BioSciences,. However, Esperion Therapeutics is 2.55 times more volatile than Pacira BioSciences,. It trades about 0.31 of its potential returns per unit of risk. Pacira BioSciences, is currently generating about 0.06 per unit of risk. If you would invest 203.00 in Esperion Therapeutics on September 2, 2024 and sell it today you would earn a total of 77.00 from holding Esperion Therapeutics or generate 37.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Esperion Therapeutics vs. Pacira BioSciences,
Performance |
| Timeline |
| Esperion Therapeutics |
| Pacira BioSciences, |
Esperion Therapeutics and Pacira BioSciences, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Esperion Therapeutics and Pacira BioSciences,
The main advantage of trading using opposite Esperion Therapeutics and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.| Esperion Therapeutics vs. Elanco Animal Health | Esperion Therapeutics vs. SIGA Technologies | Esperion Therapeutics vs. Catalent | Esperion Therapeutics vs. ANI Pharmaceuticals |
| Pacira BioSciences, vs. Phibro Animal Health | Pacira BioSciences, vs. Dr Reddys Laboratories | Pacira BioSciences, vs. Collegium Pharmaceutical | Pacira BioSciences, vs. Prestige Brand Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |